Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of the American Heart Association|May 8, 2016
Cost-Effectiveness of Ivabradine for Heart Failure in the United StatesAnuraag R Kansal, Martin R Cowie, Adrian Kielhorn, et al.
The American Journal of Managed Care|January 2, 2025
Cost-effectiveness of a multicancer early detection test in the USAnuraag R Kansal, Ali Tafazzoli, Alissa Shaul, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 27, 2025
Impact of Population Cancer Risk on the Cost-effectiveness of Multi-cancer Early Detection Testing in the USSana Raoof, Anuraag R Kansal, Ali Tafazzoli, et al.
Pharmacoeconomics - Open|December 23, 2025
Potential Economic Value of Multi-cancer Early Detection Testing Under Differential Cost Trends for Cancer Screening and ManagementAnuraag R Kansal, Ali Tafazzoli, Weicheng Ye, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 4, 2022
A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fractionAli Tafazzoli, Odette S Reifsnider, Leana Bellanca, et al.
Pharmacoeconomics|August 29, 2022
The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USAAli Tafazzoli, Scott D Ramsey, Alissa Shaul, et al.
Current Medical Research and Opinion|October 14, 2016
Financial impact of ivabradine on reducing heart failure penalties under the Hospital Readmission Reduction ProgramAnuraag R Kansal, Stanimira Krotneva, Ali Tafazzoli, et al.
Iranian Journal of Pharmaceutical Research : IJPR|April 16, 2014
Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residentsShadi Baniasadi, Maryam Habibi, Roodabeh Haghgoo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 26, 2022
Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challengeRon L H Handels, Colin Green, Anders Gustavsson, et al.
Pageof 2